2005•International Journal of Gynecology & ObstetricsRequires access

Cervical ripening and labor induction with 25 μg vs. 50 μg of intravaginal misoprostol

Elhassan M. Elhassan, O. A. Mirghani, Ishag Adam

Open publisher page 9 citations

Abstract

Various obstetrical and medical reasons necessitate induction of labor; its success depends mainly on the condition of the cervix. Misoprostol a synthetic prostaglandin E1 analog originally manufactured for prevention and treatment of peptic ulcer is as effective as dinoprostone for cervical ripening and labor induction; it costs much less than dinoprostone and does not require refrigeration. It can be applied with various routes and doses however 50 Ag or higher doses might be associated with a higher incidence of adverse effects. An open randomized controlled clinical trial was conducted at the labor ward ofWad Medani Hospital Sudan to test the efficacy of 25 Ag vs. 50 Ag intravaginal misoprostol for cervical ripening and labor induction. (excerpt)

About this research paper

What this paper is about

Various obstetrical and medical reasons necessitate induction of labor; its success depends mainly on the condition of the cervix. Misoprostol a synthetic prostaglandin E1 analog originally manufactured for prevention and treatment of peptic ulcer is as effective as dinoprostone for cervical ripening and labor induction; it costs much less than dinoprostone and does not require refrigeration. It can be applied with various routes and doses however 50 Ag or higher doses might be associated with a higher incidence of adverse effects. An open randomized controlled clinical trial was conducted at the labor ward ofWad Medani Hospital Sudan to test the efficacy of 25 Ag vs. 50 Ag intravaginal misoprostol for cervical ripening and labor induction. (excerpt)

Why it matters

OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Various obstetrical and medical reasons necessitate induction of labor; its success depends mainly on the condition of the cervix. Misoprostol a synthetic prostaglandin E1 analog originally manufactured for prevention and treatment of peptic ulcer is as effective as dinoprostone for cervical ripening and labor induction; it costs much less than dinoprostone and does not require refrigeration. It can be applied with various routes and doses however 50 Ag or higher doses might be associated with a higher incidence of adverse effects. An open randomized controlled clinical trial was conducted at the labor ward ofWad Medani Hospital Sudan to test the efficacy of 25 Ag vs. 50 Ag intravaginal misoprostol for cervical ripening and labor induction. (excerpt)

Key concepts: Medicine, Misoprostol, Labor induction, Ripening, Induction of labor, Intravaginal administration, Obstetrics, Gynecology

Related papers

Back to paper searchBrowse research topicsOriginal source
Cervical ripening and labor induction with 25 μg vs. 50 μg of intravaginal misoprostol — Research Paper | ScholarLens